DrugPatentWatch Database Preview
Hyaluronidase - Biologic Drug Details
» See Plans and Pricing
Summary for hyaluronidase
Tradenames: | 3 |
Patents: | 493 |
Applicants: | 3 |
BLAs: | 3 |
Suppliers: see list | 2 |
Recent Clinical Trials: | See clinical trials for hyaluronidase |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for hyaluronidase |
Recent Clinical Trials for hyaluronidase
Identify potential brand extensions & biosimilar entrants
Sponsor | Phase |
---|---|
Takeda | Phase 1/Phase 2 |
Brigham and Women's Hospital | Early Phase 1 |
Academic and Community Cancer Research United | Phase 2 |
Recent Litigation for hyaluronidase
Identify key patents and potential future biosimilar entrants
District Court Litigation
Case Name | Date |
---|---|
Par Pharmaceutical, Inc. v. Amneal Pharmaceuticals of New York, LLC | 2018-12-19 |
KYTHERA BIOPHARMACEUTICALS, INC. v. SLAYBACK PHARMA LLC | 2018-11-08 |
Halozyme, Inc. v. Lee | 2016-12-19 |
See all hyaluronidase litigation
PTAB Litigation
Petitioner | Date |
---|---|
2017-05-30 | |
2017-01-31 |
Company Disclosures: US Patents for hyaluronidase
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Halozyme Therap | HYLENEX RECOMBINANT | hyaluronidase recombinant human | INJECTABLE;INJECTION | 021859 | 001 | 2005-12-02 | Start Trial | Halozyme, Inc. (San Diego, CA) | 2039-09-22 | RX | company | |
Halozyme Therap | HYLENEX RECOMBINANT | hyaluronidase recombinant human | INJECTABLE;INJECTION | 021859 | 001 | 2005-12-02 | Start Trial | Halozyme, Inc. (San Diego, CA) | 2023-03-05 | RX | company | |
Halozyme Therap | HYLENEX RECOMBINANT | hyaluronidase recombinant human | INJECTABLE;INJECTION | 021859 | 001 | 2005-12-02 | Start Trial | Halozyme, Inc. (San Diego, CA) | 2023-03-05 | RX | company | |
Halozyme Therap | HYLENEX RECOMBINANT | hyaluronidase recombinant human | INJECTABLE;INJECTION | 021859 | 001 | 2005-12-02 | Start Trial | Halozyme, Inc. (San Diego, CA) | 2023-03-05 | RX | company | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
Patent Text Search: US Patents for hyaluronidase
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Amphastar Pharm | AMPHADASE | hyaluronidase | INJECTABLE;INJECTION | 021665 | 001 | 2005-11-03 | Start Trial | Oxyrane UK Limited (Manchester, GB) | 2030-09-29 | RX | search | |
Amphastar Pharm | AMPHADASE | hyaluronidase | INJECTABLE;INJECTION | 021665 | 001 | 2005-11-03 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | search | |
Amphastar Pharm | AMPHADASE | hyaluronidase | INJECTABLE;INJECTION | 021665 | 001 | 2005-11-03 | Start Trial | Halozyme, Inc. (San Diego, CA) | 2023-03-05 | RX | search | |
Amphastar Pharm | AMPHADASE | hyaluronidase | INJECTABLE;INJECTION | 021665 | 001 | 2005-11-03 | Start Trial | Oxyrane UK Limited (Manchester, GB) VIB vzw (Ghent, BE) Universiteit Gent (Ghent, BE) | 2027-04-03 | RX | search | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for hyaluronidase
Country | Patent Number | Estimated Expiration |
---|---|---|
European Patent Office | 1641916 | Start Trial |
World Intellectual Property Organization (WIPO) | 2015123477 | Start Trial |
Mexico | 2008015166 | Start Trial |
European Patent Office | 1790665 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for hyaluronidase
Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|
90041-0 | Sweden | Start Trial | MARKNADSGODKAENNANDE NR.: EU/1/13/819/001, 2013-03-15, MIKROPLASMIN |
2017000066197 | Italy | Start Trial | PRODUCT NAME: SALE SODICO DI ACIDO DESOSSICOLICO(BELKYRA); AUTHORISATION NUMBER(S) AND DATE(S): 044896013, 20161219;IS/1/16/071/01, 20160729 |
2017006 | Lithuania | Start Trial | PRODUCT NAME: DEZOKSICHOLIO RUGSTIES NATRIO DRUSKA; REGISTRATION NO/DATE: LT/1/16/3960/001 20160909 |
C/GB13/057 | United Kingdom | Start Trial | PRODUCT NAME: OCRIPLASMIN; REGISTERED: UK EU/1/13/819/001 20130315 |
>Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |